BioSyent Inc.
BIOYF
$7.38
$0.253.51%
| Weiss Ratings | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B+ | |||
| Rating Factors | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.01 | |||
| Price History | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.16% | |||
| 30-Day Total Return | -4.98% | |||
| 60-Day Total Return | -2.84% | |||
| 90-Day Total Return | -8.02% | |||
| Year to Date Total Return | -4.07% | |||
| 1-Year Total Return | 19.41% | |||
| 2-Year Total Return | 42.76% | |||
| 3-Year Total Return | 2.63% | |||
| 5-Year Total Return | 190.34% | |||
| 52-Week High % Change | -17.08% | |||
| 52-Week Low % Change | 24.45% | |||
| Price | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.90 | |||
| 52-Week Low Price | $5.93 | |||
| 52-Week Low Price (Date) | May 14, 2024 | |||
| 52-Week High Price (Date) | Oct 03, 2024 | |||
| Valuation | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 79.45M | |||
| Enterprise Value | 68.94M | |||
| Price/Earnings (TTM) | 16.40 | |||
| Earnings Per Share (TTM) | 0.45 | |||
| Earnings Per Share Growth | 14.04% | |||
| Price/Earnings To Growth | 1.17 | |||
| Price/Sales (TTM) | 3.38 | |||
| Price/Book (Q) | 1.73 | |||
| Enterprise Value/Revenue (TTM) | 2.84 | |||
| Price | $7.38 | |||
| Enterprise Value/EBITDA (TTM) | 8.35 | |||
| Enterprise Value/EBIT | 8.92 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 11.71M | |||
| Dividend Yield | 1.79% | |||
| Div. Per Share (Most Recent) | $0.03 | |||
| Dividend Per Share (TTM) | $0.13 | |||
| Payout Ratio (TTM) | 28.59% | |||
| Dividend Per Share (Most Recent) | $0.03 | |||
| Company Info | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 905-206-0013 | |||
| Address | 2476 Argentia Road Mississauga, ON L5N 6M1 | |||
| Website | www.biosyent.com | |||
| Country | Canada | |||
| Year Founded | 2006 | |||
| Profitability | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 31.81% | |||
| Profit Margin | 20.77% | |||
| Management Effectiveness | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 16.89% | |||
| Return on Equity | 20.97% | |||
| Income Statement | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 25.56M | |||
| Total Revenue (TTM) | 25.56M | |||
| Revenue Per Share | $2.18 | |||
| Gross Profit (TTM) | 20.32M | |||
| EBITDA (TTM) | 8.69M | |||
| EBIT (TTM) | 8.13M | |||
| Net Income (TTM) | 5.31M | |||
| Net Income Avl. to Common (TTM) | 5.31M | |||
| Total Revenue Growth (Q YOY) | 3.33% | |||
| Earnings Growth (Q YOY) | 8.06% | |||
| EPS Diluted (TTM) | 0.45 | |||
| EPS Diluted Growth (Q YOY) | 10.92% | |||
| Balance Sheet | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.08M | |||
| Cash Per Share (Q) | $0.95 | |||
| Total Current Assets (Q) | 17.01M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 24.33M | |||
| Current Ratio (Q) | 4.527 | |||
| Book Value Per Share (Q) | $4.27 | |||
| Total Assets (Q) | 28.75M | |||
| Total Current Liabilities (Q) | 3.76M | |||
| Total Debt (Q) | 721.20K | |||
| Total Liabilities (Q) | 4.42M | |||
| Total Common Equity (Q) | 24.33M | |||
| Cash Flow | BIOYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 2.38M | |||
| Cash from Financing (TTM) | -5.68M | |||
| Net Change in Cash (TTM) | 3.02M | |||
| Levered Free Cash Flow (TTM) | 2.99M | |||
| Cash from Operations (TTM) | 6.31M | |||
